Naviscan readies PET biopsy

November 30, 2008 DiagnosticImaging.com. Naviscan readies PET biopsy By Greg Freiherr PET niche developer Naviscan arrived at the RSNA meeting with permission from the FDA to launch its Stereo Navigator, a biopsy guidance feature for its breast-specific PET scanner. Stereo Navigator can localize lesions as small as 2 mm. It uses a stereotactic frame fixed between the scanner's paddles to guide a biopsy needle into the breast. Localization is verified using a PET-visible line source inserted into the needle track. This allows the user to confirm trajectory and position. The PET-guidance accessory is compatible with biopsy devices from Ethicon Endo-Surgery, Hologic, and SenoRx.

See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC